AngioDynamics Z Score

ANGO Stock

USD 12.07 0.22 1.79%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out AngioDynamics Piotroski F Score and AngioDynamics Valuation analysis. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide.

AngioDynamics Invested Capital is very stable at the moment as compared to the past year. AngioDynamics reported last year Invested Capital of 109.05 Million. As of 23rd of March 2023, Invested Capital Average is likely to grow to about 148.7 M, while Capital Expenditure is likely to drop (14.5 M). AngioDynamics Interest Expense is very stable at the moment as compared to the past year. AngioDynamics reported last year Interest Expense of 619,200. As of 23rd of March 2023, Operating Expenses is likely to grow to about 224.5 M, while Direct Expenses is likely to drop about 130.8 M.

AngioDynamics Z Score Analysis

AngioDynamics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

	2020	2021	2022	2023 (projected)
Interest Expense	861 K	688 K	619.2 K	635.5 K
Gross Profit	156.79 M	165.73 M	149.16 M	145.13 M

Interest Expense Gross Profit

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current AngioDynamics Z Score

11.4

Most of AngioDynamics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioDynamics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

1.2 * (

Working Capital

Total Assets )

Second Factor

1.4 * (

Retained Earnings

Total Assets )

Thrid Factor

3.3 * (

EBITAD

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

Total Assets )

AngioDynamics Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for AngioDynamics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since AngioDynamics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AngioDynamics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AngioDynamics' interrelated accounts and indicators.

	Accounts Payable	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Shareholders Equity	Investments Current	Total Liabilities	Current Liabilities	Tax Assets	Tax Liabilities
Accounts Payable		0.04	0.01	-0.12	0.03	-0.28	-0.08	-0.09	0.18	0.3	0.09	-0.4
Total Assets	0.04		0.34	0.28	0.93	0.08	0.96	0.19	0.93	-0.33	0.4	-0.56
Current Assets	0.01	0.34		0.95	0.15	-0.09	0.47	-0.09	0.12	0.29	-0.17	0.07
Cash and Equivalents	-0.12	0.28	0.95		0.04	-0.08	0.45	-0.23	0.02	0.18	-0.35	0.26
Total Debt	0.03	0.93	0.15	0.04		0.14	0.86	0.49	0.9	-0.39	0.67	-0.7
Debt Current	-0.28	0.08	-0.09	-0.08	0.14		0.01	0.0	0.15	-0.05	-0.04	0.11
Shareholders Equity	-0.08	0.96	0.47	0.45	0.86	0.01		0.2	0.79	-0.39	0.34	-0.44
Investments Current	-0.09	0.19	-0.09	-0.23	0.49	0.0	0.2		0.16	-0.44	0.91	-0.56
Total Liabilities	0.18	0.93	0.12	0.02	0.9	0.15	0.79	0.16		-0.21	0.43	-0.63
Current Liabilities	0.3	-0.33	0.29	0.18	-0.39	-0.05	-0.39	-0.44	-0.21		-0.48	0.3
Tax Assets	0.09	0.4	-0.17	-0.35	0.67	-0.04	0.34	0.91	0.43	-0.48		-0.82
Tax Liabilities	-0.4	-0.56	0.07	0.26	-0.7	0.11	-0.44	-0.56	-0.63	0.3	-0.82

Click cells to compare fundamentals

To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.

Competition

Predict AngioDynamics

In accordance with the company's disclosures, AngioDynamics has a Z Score of 11.4. This is 68.89% higher than that of the Health Care Equipment & Supplies sector and 113.08% higher than that of the Health Care industry. The z score for all United States stocks is 30.73% lower than that of the firm.

AngioDynamics Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioDynamics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AngioDynamics could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics of similar companies.

AngioDynamics is currently under evaluation in z score category among related companies.

AngioDynamics Current Valuation Drivers

We derive many important indicators used in calculating different scores of AngioDynamics from analyzing AngioDynamics' financial statements. These drivers represent accounts that assess AngioDynamics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AngioDynamics' important valuation drivers and their relationship over time.

	2018	2019	2020	2021	2022	2023 (projected)
Net Income Per Employee	81.79 K	(207.91 K)	(39.44 K)	(34.93 K)	(40.17 K)	(41.23 K)
Revenue Per Employee	360.85 K	329.29 K	363.76 K	416.08 K	374.47 K	323.42 K
Average Assets	773.02 M	685.35 M	578.99 M	551.45 M	496.3 M	553.04 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	88.76 M	(141.35 M)	(6.82 M)	2.53 M	2.27 M	2.33 M
Earnings Before Interest Taxes and Depreciation Amortization USD	88.76 M	(141.35 M)	(6.82 M)	2.53 M	2.27 M	2.33 M
Earnings before Tax	57.78 M	(168.13 M)	(36.05 M)	(29.95 M)	(26.95 M)	(29.08 M)
Average Equity	565.84 M	573.31 M	450.95 M	430.62 M	387.56 M	420.27 M
Enterprise Value	790.67 M	372.04 M	857.27 M	762.36 M	876.72 M	823.76 M
Free Cash Flow	34.32 M	(21.79 M)	10.38 M	(22.9 M)	(20.61 M)	(21.15 M)
Invested Capital	174.35 M	130.68 M	105.4 M	121.16 M	109.05 M	149 M
Invested Capital Average	206.67 M	95.12 M	124.83 M	125.48 M	112.93 M	148.68 M
Market Capitalization	699.29 M	384.86 M	881.74 M	761.25 M	875.44 M	790.3 M
Tangible Asset Value	343.38 M	196.56 M	191.15 M	199.31 M	179.38 M	193.4 M
Working Capital	241.99 M	101.47 M	83.3 M	69.02 M	79.37 M	101 M

AngioDynamics Institutional Holders

Institutional Holdings refers to the ownership stake in AngioDynamics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AngioDynamics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AngioDynamics' value.

	Last Transaction	Type	Shares	Value
Blackrock Inc	2022-12-31	Common Shares	6.7 M	92.5 M
Victory Capital Management Inc	2022-12-31	Common Shares	4.3 M	58.7 M
Polar Capital Holdings Plc	2022-09-30	Common Shares	1.9 M	38.3 M
Vanguard Group Inc	2022-12-31	Common Shares	2.8 M	38.3 M
Dimensional Fund Advisors Lp	2022-12-31	Common Shares	2.7 M	37 M
Loomis Sayles Co L P	2022-09-30	Common Shares	1.4 M	28.4 M
State Street Corp	2022-12-31	Common Shares	2 M	27.7 M
Millennium Management Llc	2022-12-31	Common Shares	2 M	26.9 M
Systematic Financial Management Lp	2022-12-31	Common Shares	1.3 M	17.5 M
Adage Capital Partners Gp Llc	2022-09-30	Common Shares	700 K	14.3 M
Balyasny Asset Management Llc	2022-12-31	Common Shares	1 M	14.3 M

AngioDynamics Fundamentals

	Return On Equity	(0.08) %
	Return On Asset	(0.0247) %
	Profit Margin	(0.1) %
	Operating Margin	(0.07) %
	Current Valuation	516.82 M
	Shares Outstanding	39.13 M
	Shares Owned by Insiders	5.02 %
	Shares Owned by Institutions	96.21 %
	Number of Shares Shorted	1.16 M
	Price to Earning	7.90 X
	Price to Book	1.19 X
	Price to Sales	1.48 X
	Revenue	316.22 M
	Gross Profit	164.93 M
	EBITDA	88 K
	Net Income	(26.55 M)
	Cash and Equivalents	24.56 M
	Cash per Share	0.31 X
	Total Debt	25 M
	Debt to Equity	0.14 %
	Current Ratio	2.28 X
	Book Value Per Share	10.33 X
	Cash Flow from Operations	(7.19 M)
	Short Ratio	5.01 X
	Earnings Per Share	(0.84) X
	Price to Earnings To Growth	1.87 X
	Target Price	24.0
	Number of Employees	760
	Beta	0.62
	Market Capitalization	487.22 M
	Total Asset	552.75 M
	Retained Earnings	64.54 M
	Working Capital	79.53 M
	Current Asset	146.25 M
	Current Liabilities	66.73 M
	Z Score	11.4
	Net Asset	552.75 M

About AngioDynamics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AngioDynamics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now

Money Managers

Screen money managers from public funds and ETFs managed around the world

All Next

Launch Module

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics

+	0.61	VNRX	Volitionrx	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.67	ENSG	Ensign Group	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.68	NVRO	Nevro Corp	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.76	ABT	Abbott Laboratories	Fiscal Quarter End 31st of March 2023	Pair Corr

Moving against AngioDynamics

	-	0.6	MLSS	Milestone Scientific		Earnings Call This Week	Pair Corr
	-	0.7	OSUR	OraSure Technologies		Fiscal Quarter End 31st of March 2023	Pair Corr

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.

The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out AngioDynamics Piotroski F Score and AngioDynamics Valuation analysis. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Bond Directory Find actively traded corporate debentures issued by US companies
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Piotroski F Score Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Fundamental Analysis View fundamental data based on most recent published financial statements

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.84)

Revenue Per Share

8.353

Quarterly Revenue Growth

0.091

Return On Assets

(0.0247)

Return On Equity

(0.08)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

AngioDynamics Z Score

AngioDynamics Z Score Analysis

Current AngioDynamics Z Score

AngioDynamics Z Score Driver Correlations

AngioDynamics Z Score Peer Comparison

AngioDynamics Current Valuation Drivers

AngioDynamics Institutional Holders

AngioDynamics Fundamentals

About AngioDynamics Fundamental Analysis

Be your own money manager

Did you try this?

Run Money Managers Now

Money Managers

Pair Trading with AngioDynamics

Moving together with AngioDynamics

Moving against AngioDynamics

Complementary Tools for AngioDynamics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY